The NextGen Precision Health Discovery Series provides learning opportunities for UM System faculty and staff across disciplines, the statewide community and our other partners to learn about the scope of precision health research and identify potential collaborative opportunities. The series consists of monthly lectures geared toward a broad multidisciplinary audience so all can participate and appreciate the spectrum of precision health efforts.
Information about the upcoming talk, including continuing education, is available below.
For questions about this event or any others in the Discovery Series, please reach out to Mary Christie at firstname.lastname@example.org
Precision Nutrition: Optimizing Food Intake to Support Health
Speaker: Dr. Elizabeth Parks, PhD
About the Speaker
Dr. Parks received her PhD in nutritional biochemistry from the University of California-Davis and then completed a Postdoctoral Fellowship at Berkeley/UCSF in the laboratory of Marc Hellerstein, MD, PhD, an internationally-recognized expert in the study of metabolism. Dr. Parks has held academic positions at the University of Minnesota and the University of Texas Southwestern Medical Center in Dallas, where she collaborated to establish a highly successful research consortium for the study of obesity. In 2013 she moved to the University of Missouri, where she is a Professor in the Department of Nutrition and Exercise Physiology and in the Department of Medicine’s Division of Gastroenterology and Hepatology. She also serves as Associate Director of the Clinical Research Center in the Medical School's Institute for Clinical and Translational Science, where she conducts studies funded by the federal government and the pharmaceutical industry. The major research contributions of Dr. Parks’ lab emanate from her development of mass spectrometry techniques to quantitate the delivery and disposal of dietary macronutrients in animal models and in humans. Her seminal studies discovered the contribution of dietary sugars to the development of nonalcoholic fatty liver disease (NAFLD). As a result, two of her highly-cited papers have received placement by Google Scholar in the top 1% of all influential publications in Clinical Medicine. From a national service perspective, Dr. Parks has been a standing member, and chair, of numerous NIH grant review committees. She is a fellow of the AHA and The Obesity Society. Currently, she serves as president elect of The Obesity Society, the largest professional organization for the study of causes and treatments of obesity. Elizabeth is PI on an NIH collaborative project to understand treatments for NAFLD, and also a PI on an NIH-funded grant to direct an annual, isotope short-course at Vanderbilt University. Lastly, her research impact is significantly extended by her serving as a co-investigator and mentor on 9 other NIH grants at Mizzou and around the country. Dr. Parks’ current research in humans focuses on how both food composition and post-meal metabolism lead to metabolic diseases.
Continuing Professional Education Credit
Up to 1.0 contact hour will be awarded to all participants who view the live sessions in their entirety and complete the evaluation form.
University of Missouri Sinclair School of Nursing is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Midwest Multistate Division Provider Number MO1022-6
The Office of Continuing Education, School of Medicine, University of Missouri is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Office of Continuing Education, School of Medicine, University of Missouri designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
CONFLICT OF INTEREST: All persons with influence over the content of this program have been asked to disclose relevant financial interests in the last 12 months that might have an impact. John Spertus, MD, is a consultant for Jannsen, Bayer, Myokardia, Merck and Novartis, and receives research support from Abbott Vascular. No other speaker or planning committee member has a relevant financial interest.